InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,640.80
(
0.00%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.19
(
0.28%
)
Bitcoin
63,015.31
(
-0.05%
)
Post# of 642838
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oldberkeley

Send PM Follow Ignore
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

oldberkeley

Re: matt24d post# 330173

Thursday, 11/06/2014 8:31:39 AM

Thursday, November 06, 2014 8:31:39 AM

Post# of 642838

Well someone sure did not like the Data for sure.

AEZS CRL:To an extreme level. The pivotal trial didn't meet primary efficacy objective as agreed to in SPA; lack of complete and verifiable source data about patients; unexplained patient ECG readings and more. Complete new study needed.

A truly disastrous CRL. Someone on Twitter suggested that the only thing the company got right was the drug name.

Been trading a long time. A few times I've lost over 50% of my principal on these kind of biotech binary plays. Just not playing them anymore.



All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up